Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C5RE | ISIN: NL0015000HT4 | Ticker-Symbol: 63E
Tradegate
31.03.25
17:27 Uhr
4,260 Euro
-0,400
-8,58 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ONWARD MEDICAL NV Chart 1 Jahr
5-Tage-Chart
ONWARD MEDICAL NV 5-Tage-Chart
RealtimeGeldBriefZeit
4,1904,43021:57
4,3104,37022:00

Aktuelle News zur ONWARD MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ONWARD MEDICAL Aktie jetzt für 0€ handeln
MiONWARD Medical NV: ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility231The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead family to be used in a clinical feasibility study The Company is building a portfolio of purpose-designed leads to optimize delivery...
► Artikel lesen
19.03.ONWARD Medical NV: ONWARD Medical Schedules Reporting of Full Year 2024 Financial Results and Business Update Webcast322EINDHOVEN, the Netherlands, March 19, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement...
► Artikel lesen
04.03.ONWARD Medical NV: ONWARD Medical to Advance Parkinson's Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense564The Michael J. Fox Foundation for Parkinson's Research is supporting a study addressing mobility challenges in Parkinson's disease; the first participant was enrolled in late 2024 A US Department...
► Artikel lesen
25.02.ONWARD Medical NV: ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy306Study shows significant functional improvements after one year of ARC-EX Therapy Improvements were observed throughout one-year treatment period with no plateau Results demonstrate the importance...
► Artikel lesen
29.01.ONWARD Medical NV: ONWARD Medical's ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms373ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms Partnership with Lovell Government Services is providing...
► Artikel lesen
13.01.ONWARD Medical NV: ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference381CEO Dave Marver to Provide Company Update Wednesday, January 15, 2025EINDHOVEN, the Netherlands, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company...
► Artikel lesen
09.01.ONWARD Medical NV: ONWARD Medical Announces First Commercial Sales of ARC-EX System516UW Medicine and Next Steps Chicago both purchased systems in late December 2024 ARC-EX is the first and only FDA approved technology indicated to improve hand strength and sensation in people with...
► Artikel lesen
19.12.24ONWARD Medical NV: ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World's First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury470THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology...
► Artikel lesen
12.12.24ONWARD Medical NV: ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability646EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to integrating sustainable business practices EINDHOVEN, the Netherlands, Dec. 12,...
► Artikel lesen
26.11.24ONWARD Medical NV: ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights448Raised EUR 50 million in new capital with cornerstone investment from Ottobock, now the Company's top investor Signed exclusive license with CEA to develop and commercialize WIMAGINE Brain-Computer...
► Artikel lesen
19.11.24ONWARD Medical NV: ONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke414Grant supports the first clinical trials studying the potential for brain-computer interface (BCI) and artificial intelligence (AI) technology to restore thought-driven movement after stroke Funding...
► Artikel lesen
12.11.24ONWARD Medical NV: ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights489Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE...
► Artikel lesen
04.11.24Ottobock becomes Onward Medical's largest shareholder5
31.10.24ONWARD Medical NV: ONWARD ARC-EX System Named One of TIME's Best Inventions of 2024423EINDHOVEN, the Netherlands, Oct. 31, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence...
► Artikel lesen
28.10.24ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering489THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 28, 2024 (GLOBE NEWSWIRE)...
► Artikel lesen
24.10.24ONWARD Medical NV: ONWARD Medical Publishes Prospectus for Listing of New Shares424THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 24, 2024 This press release...
► Artikel lesen
24.10.24XFRA 63E: WIEDERAUFNAHME/RESUMPTION179FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
24.10.24ONWARD Medical NV: ONWARD Medical Successfully Raises EUR 50 Million in an Upsized Capital Increase with Cornerstone Investment from Ottobock SE & Co. KGaA425THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Ottobock, a global leader in the fields of prosthetics, orthotics...
► Artikel lesen
23.10.24XFRA 63E: AUSSETZUNG/SUSPENSION179DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILONWARD MEDICAL BV...
► Artikel lesen
22.10.24ONWARD Medical NV: ONWARD Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA490NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER...
► Artikel lesen
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1